Management of systemic vasculitis

被引:16
作者
Langford, CA [1 ]
机构
[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2001年 / 15卷 / 02期
关键词
vasculitis; arteritis; Wegener; treatment; toxicity; glucocorticoid; cytotoxic; cyclophosphamide; methotrexate;
D O I
10.1053/berh.2001.0144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The systemic vasculitides are a wide-ranging group of diseases that are characterized by the presence of blood vessel inflammation. Despite this common feature, each type of vasculitis has a unique variety of clinical manifestations that influences its degree of disease severity and ultimately its management. Immunosuppressive therapy forms the foundation of treatment for almost all forms of systemic vasculitis. Because of this, treatment can be associated with its own risk of morbidity, or even mortality, related to specific medication side-effects or infections which occur as a result of impaired host defences. This chapter seeks to review the approach to management in selected forms of systemic vasculitis. Questions examined include the following. When should one treat systemic vasculitis! How does the nature of the disease and its severity affect treatment decisions! What are the data regarding the effectiveness of individual therapeutic regimens?.
引用
收藏
页码:281 / 297
页数:17
相关论文
共 55 条
[1]  
ADU D, 1987, Q J MED, V62, P221
[2]  
AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550
[3]  
BENGTSSON BA, 1981, ACTA MED SCAND, V209, P347
[4]   TREATMENT OF TEMPORAL ARTERITIS WITH ADRENAL CORTICOSTEROIDS - RESULTS IN 55 CASES IN WHICH LESION WAS PROVED AT BIOPSY [J].
BIRKHEAD, NC ;
WAGENER, HP ;
SHICK, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 163 (10) :821-827
[5]   Mycophenolate mofetil for the treatment of Takayasu arteritis: Report of three cases [J].
Daina, E ;
Schieppati, A ;
Remuzzi, G .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (05) :422-426
[6]  
De Groot K, 1998, J RHEUMATOL, V25, P492
[7]   Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis - Methotrexate versus trimethoprim/sulfamethoxazole [J].
deGroot, K ;
ReinholdKeller, E ;
Tatsis, E ;
Paulsen, J ;
Heller, M ;
Nolle, B ;
Gross, WL .
ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2052-2061
[8]   WEGENERS GRANULOMATOSIS - OBSERVATIONS ON TREATMENT WITH ANTIMICROBIAL AGENTS [J].
DEREMEE, RA ;
MCDONALD, TJ ;
WEILAND, LH .
MAYO CLINIC PROCEEDINGS, 1985, 60 (01) :27-32
[9]   WEGENERS GRANULOMATOSIS - STUDIES IN 18 PATIENTS AND A REVIEW OF LITERATURE [J].
FAUCI, AS ;
WOLFF, SM .
MEDICINE, 1973, 52 (06) :535-561
[10]   CYCLOPHOSPHAMIDE-INDUCED REMISSIONS IN ADVANCED POLYARTERITIS NODOSA [J].
FAUCI, AS ;
DOPPMAN, JL ;
WOLFF, SM .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (05) :890-894